• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺局限性癌的管理

The management of localised cancer of the prostate.

作者信息

Boccon-Gibod L

机构信息

Clinique Urologique, Hôpital Bichat, Paris, France.

出版信息

Eur Urol. 1996;29 Suppl 2:62-8. doi: 10.1159/000473842.

DOI:10.1159/000473842
PMID:8717466
Abstract

Localised prostate cancer (T1/T2) can be managed using a conservative (expectant) approach or by radical treatment with curative intent. Expectant management involves observation until symptoms of local/distant progression appear. Radical treatment with intent to cure is based on the destruction (radiation therapy or cryosurgery) or removal (surgery) of the tumour. Many options are offered to patients with T1/T2 prostate cancer. Expectant therapy may be considered in patients with limited life expectancy, curative treatment should be considered in the others, taking into account the high rate of cancer-related deaths after 10 years. Moreover, accurate staging should lead to a better selection of patients likely to be cured by monotherapy (surgery or radiation therapy depending on the patient's and doctor's biases). Surgery probably offers the advantage of the certainty of removal over the hypothetical destruction of the whole tumour provided by radiation therapy.

摘要

局限性前列腺癌(T1/T2)可采用保守(观察等待)方法或采用根治性治疗。观察等待管理包括观察,直至出现局部/远处进展的症状。根治性治疗旨在通过破坏(放射治疗或冷冻手术)或切除(手术)肿瘤。对于T1/T2前列腺癌患者有多种选择。预期寿命有限的患者可考虑观察等待治疗,其他患者应考虑根治性治疗,同时要考虑到10年后与癌症相关的高死亡率。此外,准确分期应有助于更好地选择可能通过单一疗法(手术或放射治疗,取决于患者和医生的偏好)治愈的患者。手术可能具有优势,即与放射治疗对整个肿瘤的假设性破坏相比,手术能确保切除肿瘤。

相似文献

1
The management of localised cancer of the prostate.前列腺局限性癌的管理
Eur Urol. 1996;29 Suppl 2:62-8. doi: 10.1159/000473842.
2
The management of hormone refractory prostate cancer.
Eur Urol. 1996;29 Suppl 2:69-74. doi: 10.1159/000473843.
3
The role of induction androgen deprivation prior to radical prostatectomy.根治性前列腺切除术前行诱导雄激素剥夺的作用。
Eur Urol. 1996;29 Suppl 2:114-8. doi: 10.1159/000473850.
4
Radiation Therapy Oncology Group P-0014: a phase 3 randomized study of patients with high-risk hormone-naive prostate cancer: androgen blockade with 4 cycles of immediate chemotherapy versus androgen blockade with delayed chemotherapy.放射治疗肿瘤学组P-0014:一项针对高危激素初治前列腺癌患者的3期随机研究:4周期即刻化疗的雄激素阻断与延迟化疗的雄激素阻断对比。
Urology. 2003 Dec 29;62 Suppl 1:95-101. doi: 10.1016/j.urology.2003.10.001.
5
Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.局限性前列腺癌的治疗:根据其自然病程(通常进展相对缓慢),可选择观察等待、手术或放射治疗。
Prescrire Int. 2012 Oct;21(131):242-8.
6
Endocrine treatment of prostate cancer.前列腺癌的内分泌治疗
J Steroid Biochem Mol Biol. 2004 Nov;92(4):287-95. doi: 10.1016/j.jsbmb.2004.10.005. Epub 2004 Dec 31.
7
Radical prostatectomy vs radiation therapy and androgen-suppression therapy in high-risk prostate cancer.高危前列腺癌的根治性前列腺切除术与放疗和雄激素抑制治疗比较。
BJU Int. 2012 Oct;110(8):1116-21. doi: 10.1111/j.1464-410X.2012.11012.x. Epub 2012 Apr 30.
8
Management strategies for locally advanced prostate cancer.局部晚期前列腺癌的管理策略
Drugs Aging. 2006;23(2):119-29. doi: 10.2165/00002512-200623020-00003.
9
Locally advanced prostate cancer: effective treatments, but many adverse effects.局部晚期前列腺癌:治疗有效,但不良反应众多。
Prescrire Int. 2013 Jan;22(134):18-20, 22-3.
10
Medical therapy of prostate cancer. A review.前列腺癌的医学治疗。综述。
Minerva Urol Nefrol. 2005 Jun;57(2):71-84.